Aurobindo arm CuraTeQ receives Health Canada approval for bevacizumab biosimilar Bevqolva
Notice of Compliance from Health Canada enables marketing authorisation for cancer biosimilar in Canadian market
Notice of Compliance from Health Canada enables marketing authorisation for cancer biosimilar in Canadian market
The study met its primary endpoint and showed equivalent efficacy and a comparable safety profile
Subscribe To Our Newsletter & Stay Updated